William Graeme Laver

William Graeme Laver's AcademicInfluence.com Rankings

Chemistry

#2638

World Rank

#3571

Historical Rank

Organic Chemistry

#395

World Rank

#466

Historical Rank

chemistry Degrees

Download Badge

Chemistry

William Graeme Laver's Degrees

Bachelors Chemistry University of Oxford

Why Is William Graeme Laver Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William Graeme Laver's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. (1997) (955)
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution (1983) (856)
Structure of the catalytic and antigenic sites in influenza virus neuraminidase (1983) (757)
Three-dimensional structure of a complex of antibody with influenza virus neuraminidase (1987) (500)
Molecular mechanisms of variation in influenza viruses (1982) (459)
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. (1973) (417)
The neuraminidase of influenza virus (1989) (292)
Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. (1969) (292)
Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. (1998) (270)
Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase (1968) (256)
Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. (1980) (232)
Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. (1993) (212)
Studies on the origin of pandemic influenza. 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza. (1973) (197)
Initial stages in the biosynthesis of porphyrins. 2. The formation of delta-aminolaevulic acid from glycine and succinyl-coenzyme A by particles from chicken erythrocytes. (1958) (197)
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. (1992) (191)
Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. (1967) (189)
Identification in a recombinant influenza virus of structural proteins derived from both parents. (1966) (181)
STRUCTURAL STUDIES ON THE PROTEIN SUBUNITS FROM THREE STRAINS OF INFLUENZA VIRUS. (1964) (180)
Separation of two polypeptide chains from the hemagglutinin subunit of influenza virus. (1971) (172)
Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. (1979) (168)
Influenza virus neuraminidase with hemagglutinin activity. (1984) (139)
Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. (1994) (135)
The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. (1994) (135)
Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. (1995) (134)
The structure of influenza viruses. IV. Chemical studies of the host antigen. (1963) (122)
Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores. (2001) (121)
Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase. (1985) (114)
Studies on the size, chemical composition, and partial sequence of the neuraminidase (NA) from type A influenza viruses show that the N-terminal region of the NA is not processed and serves to anchor the NA in the viral membrane. (1982) (111)
Protection against lethal influenza with neuraminidase. (1988) (111)
Studies on the origin of pandemic influenza. I. Antigenic analysis of A 2 influenza viruses isolated before and after the appearance of Hong Kong influenza using antisera to the isolated hemagglutinin subunits. (1972) (110)
Antigenic structure and variation in an influenza virus N9 neuraminidase (1987) (107)
Purification and properties of chick embryo lethal orphan virus (an avian adenovirus). (1971) (104)
Reactions of antibodies with surface antigens of influenza virus. (1968) (103)
The Structure of Influenza Viruses. 3. Disruption of the Virus Particle and Separation of Neuraminidase Activity. (1963) (102)
Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. (1992) (97)
Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies. (1982) (97)
Selection of antigenic mutants of influenza viruses. Isolation and peptide mapping of their hemagglutination proteins. (1968) (92)
Structures of aromatic inhibitors of influenza virus neuraminidase. (1995) (90)
Amino acid sequence changes in the haemagglutinin of A/Hong Kong (H3N2) influenza virus during the period 1968–77 (1980) (90)
Disarming flu viruses. (1999) (90)
Isolation of an arginine-rich protein from particles of adenovirus type 2. (1970) (88)
Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism. (1994) (87)
Isolation of a type A influenza virus from an Australian pelagic bird. (1973) (87)
Evolutionary changes in influenza B are not primarily governed by antibody selection. (1990) (87)
Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98) (2002) (86)
Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies. (1979) (85)
Crystallization and peptide maps of neuraminidase "heads" from H2N2 and H3N2 influenza virus strains. (1978) (84)
Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus (1988) (84)
Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains. (1974) (82)
An 18-amino acid deletion in an influenza neuraminidase. (1985) (81)
Three-dimensional structures of influenza virus neuraminidase-antibody complexes. (1989) (81)
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. (1997) (81)
Initial stages in the biosynthesis of porphyrins. I. The formation of delta-am-inolaevulic acid by particles obtained from chicken erythrocytes. (1958) (80)
The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution. (1996) (76)
Studies on the origin of pandemic influenza. II. Peptide maps of the light and heavy polypeptide chains from the hemagglutinin subunits of A 2 influenza viruses isolated before and after the appearance of Hong Kong influenza. (1972) (76)
Inhibition of Virus Release by Antibodies to Surface Antigens of Influenza Viruses (1974) (72)
Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies. (1984) (72)
Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Antiinfluenza Activity. (1997) (71)
Mechanism of antigenic drift in influenza virus. Amino acid sequence changes in an antigenically active region of Hong Kong (H3N2) influenza virus hemagglutinin. (1981) (70)
Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. (1976) (70)
The origin of pandemic influenza. (1972) (69)
Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface. (1992) (69)
Removal of pentons from particles of adenovirus type 2. (1969) (69)
Ecology of influenza viruses in lower mammals and birds. (1979) (67)
Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus. (1966) (66)
A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. (1995) (66)
Isolation of an internal component from adenovirus type 5. (1968) (65)
Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. (1995) (64)
Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase. (1982) (62)
Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine. (1976) (60)
Antigenic Variation Among Type A Influenza Viruses (1983) (60)
The Polypeptides of Influenza Viruses (1973) (59)
Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants. (1984) (59)
Purification, thioredoxin renaturation, and reconstituted activity of the three subunits of the influenza A virus RNA polymerase. (1988) (55)
The Origin and Control of Pandemic Influenza (2000) (55)
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors. (2005) (55)
Binding of antibodies to isolated haemagglutinin and neuraminidase molecules of influenza virus observed in the electron microscope. (1977) (54)
Potentiation of the immune response to influenza virus subunit vaccines. (1977) (53)
Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase (1990) (51)
Crystal structures of neuraminidase-antibody complexes. (1989) (51)
Distribution of sequence differences in influenza N9 neuraminidase of tern and whale viruses and crystallization of the whale neuraminidase complexed with antibodies. (1987) (51)
Detection and isolation of H5N1 influenza virus from large volumes of natural water. (2008) (50)
Influenza virus recombination. I. Matrix protein markers and segregation during mixed infections. (1976) (46)
The ecology of influenza. Isolation of type 'A' influenza viruses from Australian pelagic birds. (1977) (45)
GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains. (1998) (44)
A single sequence change destabilizes the influenza virus neuraminidase tetramer. (1997) (43)
Gene and protein sequence of an influenza neuraminidase with hemagglutinin activity. (1985) (41)
Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors (1997) (41)
The molecular basis of antigenic variation in influenza virus. (1986) (40)
The Influenza Virus Hemagglutinin (1978) (40)
Novel α- and β-Amino Acid Inhibitors of Influenza Virus Neuraminidase (2001) (39)
A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity. (1998) (38)
Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses. (1969) (37)
Methods in immunochemistry of viruses. 3. Simple techniques for labelling antibodies with 131-I and 35S. (1961) (37)
Antigenic variation in influenza viruses. (1987) (36)
Data for Drug Design. (Book Reviews: Use of X-Ray Crystallography in the Design of Antiviral Agents.) (1990) (36)
Structural analysis of an electrophoretically cryptic alcohol dehydrogenase variant from an Australian population of Drosophila melanogaster. (1981) (35)
Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase (1994) (34)
Structure of an escape mutant of glycoprotein N2 neuraminidase of influenza virus A/Tokyo/3/67 at 3 A. (1988) (33)
Structure and variation in influenza virus : proceedings of the International Workshop on Structure and Variation in Influenza Virus, Thredbo, Australia, December 10-12, 1979 (1980) (32)
Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. (1997) (32)
Catalysis by Two Sialidases with the Same Protein Fold but Different Stereochemical Courses: A Mechanistic Comparison of the Enzymes from Influenza A Virus and Salmonella typhimurium (1994) (32)
Electron and X-ray diffraction studies of influenza neuraminidase complexed with monoclonal antibodies. (1986) (31)
Antigenic, sequence, and crystal variation in influenza B neuraminidase. (1990) (31)
Sequence of the hemagglutinin gene of influenza virus A/Memphis/1/71 and previously uncharacterized monoclonal antibody-derived variants. (1983) (30)
Adenovirus Proteins II. N-Terminal Amino Acid Analysis (1967) (29)
Studies on the origin of pandemic influenza viruses V. Persistence of Asian influenza virus hemagglutinin (H2) antigen in nature? (1975) (28)
Amino acid composition of polypeptides from influenza virus particles. (1972) (26)
Sialic acid is cleaved from glycoconjugates at the cell surface when influenza virus neuraminidases are expressed from recombinant vaccinia viruses. (1989) (25)
Antibodies to human influenzavirus neuraminidase (the A-Asian-57 H2N2 strain) in sera from Australian pelagic birds. (1972) (25)
Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity. (1995) (25)
How antibodies recognize virus proteins. (1987) (24)
The structure of influenza viruses. I.N-terminal amino acid analyses. (1962) (24)
Crystals of antibodies complexed with influenza virus neuraminidase show isosteric binding of antibody to wild-type and variant antigens. (1987) (24)
Crystalline monoclonal fab fragment with specificity towards an influenza virus neuraminidase. (1981) (24)
Purification, N-terminal amino acid analysis, and disruption of an influenza virus. (1961) (23)
Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture. (1997) (23)
THE MECHANISM OF ANTIGENIC DRIFT IN INFLUENZA VIRUSES: ANALYSIS OF HONG KONG (H3N2) VARIANTS WITH MONOCLONAL ANTIBODIES TO THE HEMAGGLUTININ MOLECULE * (1980) (22)
A micromethod for the N-terminal amino acid analysis of proteins. (1961) (21)
Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses. (1976) (21)
Approaches and Strategies for the Treatment of Influenza Virus Infections (1999) (21)
Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains. (1985) (19)
Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm. (2002) (19)
287. α-Amino-β-keto-acids. Part II. Rates of decarboxylation of the free acids and the behaviour of derivatives on titration (1959) (18)
Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine (1976) (18)
Purification of thyroid protease by acetone fractionation. (1955) (17)
Antigenic variation in influenza virus. Biology and chemistry. (1971) (16)
The effect of antineuraminidase antibody on the elution of influenza virus from cells. (1968) (16)
Antibodies to influenza viruses (including the human A2-Asian-57 strain) in sera from Australian shearwaters (Puffinus pacificus). (1970) (14)
286. α-Amino-β-keto-acids. Part I. Synthesis and attempted isolation of the free acids (1959) (14)
Antibody recognition of the influenza virus neuraminidase. (1989) (13)
Characterization and ecology of a type A influenzavirus isolated from a sheawater. (1973) (13)
The mechanism of antigenic drift in influenza virus: sequence changes in the haemagglutinin of variants selected with monoclonal hybridoma antibodies. (1980) (13)
The molecular size of neuraminidase from Vibrio cholerae (strain 4Z) (1964) (13)
Hemagglutinin molecules of Hong Kong, equine-2, and duck/Ukraine influenza viruses lack N-terminal aspartic acid. (1977) (13)
Crystallization and preliminary X-ray analyses of two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40. (1988) (13)
Crystallization of antibody-protein complexes (1990) (12)
Crystallization of biologically active hemagglutinin-neuraminidase glycoprotein dimers proteolytically cleaved from human parainfluenza virus type 1 (1992) (12)
Complex nature of the proteolytic system of the thyroid gland. (1956) (11)
Preliminary crystallographic data for influenza virus neuraminidase "heads". (1978) (11)
Benzoic acid inhibitors of influenza virus neuraminidase. (1995) (11)
Crystallization of Sendai virus HN protein complexed with monoclonal antibody Fab fragments. (1989) (10)
Immune recognition of protein antigens. (1985) (10)
Comparison of adenovirus types 2 and 5 hexons by immunological and biochemical techniques. (1970) (10)
Towards a universal influenza vaccine. (1980) (10)
B-cell or T-cell immunity? (1982) (8)
ANTIGENIC DRIFT IN INFLUENZA VIRUSES AND ASSOCIATION OF BIOLOGICAL ACTIVITY WITH THE TOPOGRAPHY OF THE HEMAGGLUTININ MOLECULE (1981) (8)
Unusual diffraction of type B influenza virus neuraminidase crystals. (1992) (8)
Three antibody molecules can bind simultaneously to each monomer of the tetramer of influenza virus neuraminidase and the trimer of influenza virus hemagglutinin (2005) (8)
FIRST CRYSTAL STRUCTURE OF A BACTERIAL SIALIDASE SHOWS SAME FOLD AS INFLUENZA VIRUS NEURAMINIDASE (1993) (7)
Crystallization and preliminary X-ray analysis of type B influenza virus neuraminidase complexed with antibody Fab fragments. (1988) (7)
Reappearance in 1979 of a 1968 Hong Kong-like influenza virus. (1981) (6)
From the Great Barrier Reef to a "Cure" for the Flu: tall tales, but true (2004) (6)
STRUCTURE AND VARIATION OF ANTIGENIC SITES ON INFLUENZA VIRUS HEMAGGLUTININ (1981) (5)
Antigenicity of influenza virus hemagglutinin following chemical modification. (1981) (5)
New crystalline forms of neuraminidase of type B human influenza virus. (1990) (5)
Antigenic relationships among influenza virua A neuraminidase (N2) antigens by immunodiffusion and postinfection neutralization tests (1976) (5)
ORIGINS OF PANDEMIC INFLUENZA (1973) (5)
Novel alpha- and beta-amino acid inhibitors of influenza virus neuraminidase. (2001) (5)
Crystals of hemagglutinin-neuraminidase of parainfluenza virus contain triple-stranded helices. (1993) (3)
58 Design, synthesis and activity of substituted pyrrolidine influenza neuraminidase inhibitors (2000) (3)
Resistance of influenza A and B viruses to 4-guanidino-Neu5Ac2en (1996) (3)
Corrigendum to ‘Design, Synthesis, and Neuraminidase Inhibitory Activity of GS-4071 Analogues that Utilize a Novel Hydrophobic Paradigm’ ☆: [Bioorg. Med. Chem. Lett. 12 (2002) 3425] (2003) (3)
Antigenic variation and the structure of influenza virus glycoproteins. (1984) (2)
NIAID News. Summary of a meeting on structure and variation in influenza viruses. (1980) (2)
Book Review Hunting the 1918 Flu: One Scientist's Search for a Killer Virus By Kirsty Duncan. 297 pp., illustrated. Toronto, University of Toronto Press, 2003. $35. 0-8020-8748-5 (2004) (2)
From the National Institutes of Health. Summary of a meeting on the origin of pandemic influenza viruses. (1984) (2)
Antigenic Determinants on the Hemagglutinin Subunits of Influenza a Viruses and Their Role in Immunity (1978) (2)
Disarming Flu Viruses Coming soon : new medicines designed to treat the flu by halting viral replication in human tissues (1999) (2)
Novel a- and b-Amino Acid Inhibitors of Influenza Virus Neuraminidase (2001) (2)
Electron Microscopy of Antibodies Bound to Isolated Influenza Hemagglutinin (1978) (2)
The origin of pandemic strains of influenza. Evidence from studies of the structure of the hemagglutinin subunits. (1972) (1)
The influenza virus hemagglutinin symposium, Baden near Vienna, March 21-23, 1977 (1978) (1)
VIBRIO CHOLERAE NEURAMINIDASE (1997) (1)
Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 43 hours at 291 K. (2006) (1)
Towards the structure of hemagglutinin-neuraminidase from Newcastle disease virus (1996) (1)
Potentiation of the immune response to influenza virus subunit vaccines. (1977) (1)
INFLUENZA VIRUS NEURAMINIDASE: STRUCTURE AND VARIATION (1984) (1)
The structure of a complex between influenza virus neuraminidase and an antibody (1987) (1)
Virus infection and the cell surface: edited by George Poste and Garth L. Nicolson, published by North-Holland, Amsterdam, 1977. Dfl. 137.− ($55.95) (xix + 342 pages) (1977) (1)
Structure of Neuraminidase Subtype N9 Complexed with 30 MM Sialic Acid (NANA, NEU5AC), Crystal Soaked for 24 Hours at 291 K and Finally Backsoaked for 30 Min in a Cryoprotectant Solution which did not contain NEU5AC (2007) (0)
A structural comparison of bacterial and viral neuraminidases (1993) (0)
The Origin of pandemic influenza viruses : proceedings of the International Workshop on the Molecular Biology and Ecology of Influenza Virus held in Peking, China, November 10-12, 1982 (1983) (0)
SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH EPANA INHIBITOR (1996) (0)
THE STRUCTURES OF SALMONELLA TYPHIMURIUM LT2 NEURAMINIDASE AND ITS COMPLEX WITH A TRANSITION STATE ANALOGUE AT 1.6 ANGSTROMS RESOLUTION (1994) (0)
Purification, renaturation and in vitro transcriptase activity of the three subunits of influenza a virus RNA polymerase (1988) (0)
Antivirals for influenza infection (1996) (0)
Influenza Virus N9 Neuraminidase A complex with Zanamivir molecule (Tern). (2018) (0)
Heterogeneity of neuraminidase genetic information in an H1N2 reassortant influenza virus [X-7 (F1)] (2005) (0)
Antigenicity oftheN8Influenza A Virus Neuraminidase: Existence ofanEpitope attheSubunit Interface oftheNeuraminidase (1994) (0)
The three-dimensional structure of neuraminidase of subtype N9 (1987) (0)
Influenza A Virus N9 Neuraminidase complex with Oseltamivir (Tern). (2018) (0)
CRYSTALLOGRAPHY OF BIOLOGICAL MACROMOLECULES (2008) (0)
The structure of the neuraminidase glycoprotein of influenza virus (Tokyo/3/67) at 2.4 Ã resolution (1987) (0)
Influenza A Virus N9 Neuraminidase complex with NANA (Tern/Australia). (2018) (0)
Salmonella typhimurium neuraminidase mutant (D100S) (2020) (0)
Crystalline influenza virus neuraminidase antibody complexes (1985) (0)
SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH APANA AND EPANA INHIBITORS (1996) (0)
Influenza A Virus N9 Neuraminidase Native (Tern). (2018) (0)
Salmonella typhimurium mutant neuraminidase (D100S)+ DANA (2020) (0)
Structure of Neuraminidase from English Duck Subtype N6 Complexed with 30 MM ZANAMIVIR, Crystal Soaked for 3 Hours at 291 K. (2007) (0)
Structure of Neuraminidase from English duck subtype N6 (2006) (0)
Influenza A virus N6 neuraminidase complex with DANA (Duck/England/56). (2018) (0)
Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 277 K. (2006) (0)
Structural studies of type-B neuraminidase (1993) (0)
Structure of Neuraminidase Subtype N9 Complexed with 30 MM Sialic Acid (NANA, NEU5AC), Crystal Soaked for 3 Hours at 291 K. (2007) (0)
Salmonella typhimurium neuraminidase in complex with isocarba-DANA. (2020) (0)
The structure of Salmonella typhimurium LT2 neuraminidase at 1.6 (1993) (0)
Influenza B/Lee/40 neuraminidase: X-ray structure of enzyme complexed with 4-guanidino-Neu5Ac2en (1996) (0)
influenza virus N9 neuraminidase. Antigenic structure and variation in an (2013) (0)
The crystal structure of antibodies complexed with influenza virus neuraminidase (NA) (1988) (0)
7 – Recognition of Protein Antigens by Antibodies: Crystal Structure of Antibody Fab Fragments Complexed with Influenza Virus Neuraminidase (1990) (0)
The 3-Dimensional Structures of Influenza Virus Neuraminidase and an Antineuraminidase Fab Fragment (1987) (0)
Crystal structure of influenza virus neuraminidase with inhibitor 3,5-diguanidino-4-(N-acetylamino)benzoic acid (1996) (0)
5 – Crystal Structures of Influenza Virus Neuraminidase Complexed with Monoclonal Antibody Fab Fragments (1990) (0)
Sperm Cells as DNA Vectors for the Preparation of Transgenic Animals (2007) (0)
Influenza A virus N6 neuraminidase complex with Oseltamivir (Duck/England/56). (2018) (0)
Immunochemistry of variants of influenza virus hemagglutinin and neuraminidase. (1985) (0)
Antigenic properties of influenza neuraminidases (1988) (0)
Antigenic drift in type A influenza virus: Peptide mapping and antigenic analysis of A/PR/8/34 (HONI) variants selected with monoclonal antibodies (antigenic variants/hemagglutinin/peptide maps/amino acid changes) (2016) (0)
Influenza A virus N6 neuraminidase native structure (Duck/England/56). (2018) (0)
Benzoic Acid lnhibitors of Influenza Virus Neuraminidase (1995) (0)
Salmonella typhimurium neuraminidase mutant (D62G) (2020) (0)
'N-TERMINAL AMINO ACID ANALYSIS OF HEMAGGLUTININ MOLECULES FROM DUCK AND EQUINE INFLUENZA VIRUSES PREVIOUSLY IMPLICATED AS PROGENITORS OF THE HONG KONG STRAIN OF HUMAN INFLUENZA (1978) (0)
The structure of neuraminidase (1984) (0)
Design, Synthesis, and Neuraminidase Inhibitory Activity of GS‐4071 Analogues that Utilize a Novel Hydrophobic Paradigm. (2003) (0)
Drug Development in Space? (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William Graeme Laver?

William Graeme Laver is affiliated with the following schools:

University of Alabama
University of Oklahoma Health Sciences Center
St Mary's Hospital Medical School
Cornell University
Australian National University